In conclusion, a multidisciplinary approach that includes molecular biology, pharmacology, immunology, and clinical research is required to fully understand TMPRSS2's varied role and aid the development of effective therapeutics for COVID-19 and other respiratory viral infections. The gene discussed is TMPRSS2; the disease is COVID-19.